Member Info for Thelix

Welcome to AIM - 99.999% of all companies ever listed produced absolutely nothing.

rhodi - when performing trials on ill people you cannot just take them off medication that definitely works - it is unethical. Add on trials are very normal these days and nothing to be concerned about. As to its side effect profile - most drugs have side effects so again not too worried. GWP did the same thing - their trials used combination of what the patients were already taking with the new compound. rpl554 has been proved to phase 1/2 level - it is unethical to use it as a single treatment for now. Later stage designs should see this being used as a single therapy.

In RNS's has stated H1 so should be before the results. Then again the same RNS's stated 6 months from the AIM cash raise which was January so they don't mind slipping their timelines.

wanted more detail on the reg routes. The FDA will supply that detail soon. I would NOT expect commercial partnership to occurr in the same FDA response RNS - If it does this will go ballistic. There will be negotiations and discussions with commercial partners after the FDA have made their comments and answered any of OXP's questions. Considering quite a few people were interested in partnering after the reg route is ironed out, there should be a comm partner success RNS shortly afterwards (within a few weeks). We will just have to see what the FDA expects. So long as the RNS details an easy list of things OXP have to accomplish and the FDA are happy with most things this will re rate. If the FDA RNS asks for massive changes, or requires OCP to perform more time consuming tasks, this will go down. The main issue partners had was regulatory in nature. so a red tape issue. Aka the drugs work, everything is fine, but details need to be ironed out for an ehtical legal sale of these drugs to occur. There are a few things that could throw a spanner in the works, but the majority of scenarios and expectations I can think of OXP will have covered or be able to do with ease. Very happy with my holding here. This is primed and pretty much just needs a crystal ball. Nobody knows it the news will be good or bad. All we can do is speculate, and in my educated opinion of this industry - the chances and opportunities here are great

is being wrecked today. Literally 17 out of 19 on my quickpicks are red, 1 yellow (suspended anyway) and 1 blue lol. Luckily all by trivial % and many I am just watching but still - AIM is being hammered today. Tomorrow should be a nice blue day.

starr.... No. We have 50 mil shares in issue worth 65 mil mcap. To raise 108 million pounds they need to introduce 80 million more shares. Make sense? Its all about the mcap. The mcap will go UP past 108 mil because we have that cash - the share price will remain the same =dilution. 108 mil mcap with 50 mil shares = 190p 108 mil mcap with 130 mil shares = 125p. Understand? Bewise - maybe, I have an uncanny ability to cut losses and make profits elsewhere. Its either lose 10k now or blow the whole 35k waiting for the BoD to give a damn - which they never will. We'll see. this is the heaviest I have loaded into AIM. Its all AIM profits so technically I havent lost anything if you get what I mean but...Due to the amount its playing on my psychology more than the usual £1-5k punt money on AIM

considering selling at a £10k loss here. Screw it, I will consider it over the weekend but my other investments are doing well and I am near to profit of 10k in 3 other shares so will breakeven just and load up on new companies. This could have been such a dream share if the BoD werent such tools.

starrenstoff VRP are raising 108M - fact That is nearly double the current mcap requiring 200% dilution (so your shares will be worth 3 times less) The price they can launch on NASDAQ is the MA of the shareprice. You cant just rock up to US investors and ask for money at a massive premium to the share price. AIM works in very simple ways - if a known dilution looms - the price goes into something called the "death spiral" where the SP lowers due to diluton concerns, and because the SP lowers - more dilution is inevitable, which lowers the sp, which makes more dilution, which lowers the sp. If the BoD don't sort this out quick this is blatantly going to cash in bank sp of ~35 mil meaning that 108Mil will require 350% dilution odd, making your shares worth 4.5 times less value - of the CURRENT share price. You then need to wait for it to reach your buy in price. The point I am making here is we need this to reach half a billion £ mcap to breakeven. Let me tell you now as someone who works in pharma and has been part of a NASDAQ lanch - that mcap wont happen for a while, or if it does, will be temporary. I was happy when 18Mil induced just over 100% dilution because a 500 mil mcap would have been a good 5 bagger odd. Now 500 milion mcap sees me breakeven or maybe at a slight loss. And the entire reason this is happening is due to BoD's incompetence. Many here including myself posted how NASDAQ has a minimum SP requirement and this would need consolidation. The RNS stated a NASDAQ launch 6 months from now. All they have done is consolidated by January and now left it hanging with a "H1" which gives us another 4 months of AIM dilution death spiral nonsense. Even if April sees good phase 2 results this wont recover much - maybe 100p, which is 2p old money. Why? Because this is the crappy AIM and dilution is round the corner. The entire point, and the entire reason many were excited here, was because we wanted phase 2 success while on the NASDAQ which would yield massive rerates. BoD are absolutely USELESS. Thanks for wasting my money paying your salary to stall and get your chums in on mates rates. Will never invest in a company where I see their names again and will publically warn anyone of them too if they go to new companies, and their incompetence.

will be a success and have a huge mcap, but after dilution shareprice will be same or lower. The BoD are not aligned with the shareholders, which is ironic given it is ii's buying shares that has allowed them to progress.No respect

blatantly going to drop to cash in bank which is 44mil max as they have setup trials so more like 35m this is personally going to 70p and induce 3-4x more dilution than was necessary if the BoD fulfilled their 6 month timeline. Very unimpressed with requiring a massive multibagger just to get my stake back. Blatant mates rates nonsense here. I am confident I will get my money back but not much more. I said this will 5 bag short term on NASDAQ but thanks to extra dilution that could have been avoidee that 5 bagger puts many here back to square 1. Terrible strategy by the BoD. Time to add their names to my spreadsheet of "AVOID LIKE THE PLAGUE"

They could have consolidated when it was 4p and suffered only 100% dilution and launched on NASDAQ quick like GWP.

The NASDAQ launch will boost the SP. But if this dwindles to cash levels it needs to 3-4 bag for the majority of PI's to break even - not good

is still money to be made bewise. The issue I am having is every extra 100% dilution this sees ( was near 100% will soon be 200%) I lose a potential £35k from that "bag" that has been eaten up by said dilution. If this 10 bags but requires 200% dilution then I will only get 8 bags. I have a lot of money in here and every time the price goes down a few % I am not only losing on paper, but the 108M makes tear inducing dilution % which knocks back final profits considerably

i was banking on this going to 500 mil mcap short term If I am correct about the sp reaching cash in bank mcap, and we dilute for the 108m cash, that 500mcap will be approx 190p a share - my breakeven point. Basically this will have had a 4-5 mcap bagger with no change in SP. Craps on the PI's.

Yes the fundamentals are the same but 108m is going to be raised. That 108M can lead to 80% dilution, 200% dilution, 400% dilution. The issue is dilution is headed which will drive the SP lower - increasing dilution, which makes the SP lower. This is clearly going to drop to cash levels which is approx 70p. This is more than likely going to 70p which will initiate nearly 300% dilution. Had the BoD got on with NASDAQ by end of Jan it would be 100% dilution. Pretty grim, pretty amatuer, or pretty obvious mates rates stitch up.

textbook OXP. I remember KUMS you being here in the '15 rerate. We have both seen this pattern and know where it is going. OXP motors on tiny volume due to freefloat and sells tend to spur book balancing and just allows the next leg up. The herd clearly had a little play last week and we got a 50-60% rise with a 15% drop and now two consecutive 5% blue days. This will be pushing into 4's in no time.

i do disagree with armyboys obsession with the idea that all good compounds are bought out instantly and that this drop is due to consolidation - The SP has been in freefall way before the consolidation news even came out. I dont think the SP reflects 554 or its capability. I just think the BoD have managed the NASDAQ launch TERRIBLY This was actually floating 30% above placement price which in AIM land is unheard of. They stated they would fulfill NASDAQ listings by January and instead just consolidated and mentioned "H1". The issue is people know dilution is coming and that has tanked the SP so it will be MORE dilution. They should have copied GWP's strategy and launched quickly. Again this will rerate on NASDAQ. The issue is at this rate we will have a 200% dilution for that 108 million quid. It was only a tad over 100% dilution for the same amount of money IF VRP actually listed in January which the RNS wording suggested. Very unhappy with the BoD here now actually, pretty pathetically amatuer how they have dealt with this, which is why I suspect a huge mates rates shenanigans is happening.

I think Armyboy is right. This is in freefall with minimal selling volume I can see this heading significantly lower than 100p prior to NASDAQ launch. I have a hunch a massive mates rates screwover of PI's is happening here. Still, given the mcap and potential this is multibagger potential. Its just a shame that after dilution it will need to 3-4 bag for me to get my money back by looks of things. I recommend a sell from here, and a biy @ circa 60-70p which I reckon might happen

Hopefully they release April data before NASDAQ launch. Some NASDAQ investors may have already said only once phase 2 passes - I think similar terms were made with GWP. I am still confident this will come good but the consistent decline is psychologically disheartening to say the least. Fully loaded here so no sofa cash for me. Already got 50% of liquid AIM profits in here and wont go more than that. I have been at OXP another pharma co I got in at 2.35p. If people here like investing in pharma its a goodun.

anything, the info I posted is my experiences in the industry, not necessarily the position OXP are in -just educated estimations. For all we know OXP have fulfilled minimal criteria and the FDA might overwhelm them and require a lot of work. But I would say that is highly unlikely. I have put 10k where my mouth is, and stated back in '16 when I bought at 6p and also stated averaging down at 1.8p prior to the big rise. I havent just appeared during the rise pumping this lol. It has been a frustrating 6-7 months watching that 6p fall to 1.8p but hey got an average of 2.35p and not planning on top slicing until 10p minimum. This is still a very low price at just 40% higher than cash in bank for a pharma company. I am hoping today and tomorrow see blue days and we break that 3.6p resistance.